Update portfolioPage “portfolioPage”

content/portfolioPage.md

@@ -1180,4 +1180,130 @@ portfolio:
     type: 医疗健康
     website: http://www.galixir.com
     description: 星药科技（Galixir）成立于2019年，是一家使用尖端人工智能技术赋能药物研发的公司。星药通过使用人工智能的前沿算法，结合计算化学和药物化学的工具及经验，全方位攻克小分子药物早期研发流程中的疑难问题。星药正在和国内外药企以及研究机构合作推进多个药物研发管线。经星药Pyxir™药物研发平台所涉及和筛选的新药候选分子，具有良好的专利空间和超越阳性药水平的高活性。星药将单个临床前药物研发管线的成本和时间大幅降低和缩短，使得同时储备多条药物研发管线、优化整体战略布局都成为了可能。
+  - descriptionEN: 4B Technologies is a biopharmaceutical company with the goal of
+      developing innovative treatments for nervous system disorders through
+      internal innovations as well as partnerships around the globe. Our
+      management team comprises veteran leaders in science and technology,
+      business, and operations, who have passion, industry experience and track
+      record in neuroscience drug discovery and development and
+      commercialization. Innovation, energy, growth, collaboration,and
+      patient-oriented are our culture and core value. Employees are growing
+      together with the company to create a long- term vibrant, impactful, and
+      sustainable future.
+    logo2: /static/img/4blogo.png
+    sinceDate: 2019-10-15T12:37:32.377Z
+    logo: /static/img/4blogo.png
+    name: 福贝生物
+    nameEN: 4B Technologies
+    type: 医疗健康
+    website: http://www.4btechnologies.com/index.aspx
+    description: 福贝生物科技(苏州)有限公司是一家致力于开发治疗神经系统疾病的创新药物和开拓相关前沿技术平台的生物制药高新技术企业。福贝生物由国际顶尖级科学家领衔，已建立了由来自于企业运营、新药研发、学术突破和商务等领域精英人士组成的领导团队。福贝生物追求创新活力成长、以患者为本的企业文化，具有宏远的企业发展规划，公司员工将与公司共同进步和发展。
+  - sinceDate: 2020-07-30T12:38:34.032Z
+    name: 凯思凯迪
+    nameEN: Cascade
+    description: 凯思凯迪成立于2017年12月，是一家中外合资性质的生物医药研发新锐企业，聚焦核受体创新药物的早期发现、药物开发和后续商业化。公司研发团队由国际知名结构生物学家和顶尖核受体领域科学家共同领衔组成，在以核受体为靶标的代谢性疾病、肿瘤和炎症等领域，该研发团队有20余年的创新药研发积累，同时是全球基于蛋白三维结构开展药物开发设计的先导者。凯思凯迪以自主研发为主，建立了丰富且风险平衡的1类新药产品管线，目前已有十多款候选药物；核心品种靶向FXR的非胆酸类完全激动剂药物分子CS0159预定2021年7月同时向FDA和NMPA申报临床试验注册。
+    descriptionEN: Cascade, founded in December 2017, is a Sino-foreign joint
+      venture biomedical enterprise, focusing on the drug discovery, development
+      and subsequent commercialization of innovative nuclear receptor drugs. The
+      core R&D team is jointly led by internationally renowned structural
+      biologists and top nuclear receptor scientists. The team has accumulated
+      more than 20 years of innovative drug research and development in the
+      fields of metabolic diseases, tumor and inflammation targeting nuclear
+      receptors, leading the way in structure based drug design. Cascade,
+      concentrating on independent research and development, has established a
+      rich and risk-balanced Class 1 new drug pipeline. Currently, there are a
+      dozen of drug candidates, of which the core product of a non-cholic acid
+      drug molecule CS0159 targeting FXR will be scheduled to simultaneously
+      apply for clinical trial registration to the FDA and NMPA in July 2021.
+    type: 医疗健康
+    logo: /static/img/kaisikaidilogo.png
+    logo2: /static/img/kaisikaidilogo.png
+  - descriptionEN: MingMed Biotech is a clinical stage platform company dedicated to
+      developing First-in-Class pharmaceutical products. Our R & D team is
+      formed by globally top-notch scientists and specialists, while our
+      scientific committee consists of influential scientists in the world. We
+      have already made world-class breakthroughs in developing novel therapies
+      in the fields of ophthalmology, immune-oncology, gene editing-based
+      immunotherapy, medical aesthetics and pet medicine. There are currently
+      over 10 products in our R&D pipeline, most of which are First-in-Class
+      medications for unmet medical needs and already in either clinical or
+      preclinical stages. MindMed is committed to develop innovative medicines
+      targeting the true causes of diseases. With this mission, MindMed strives
+      to be a leading biopharma company in the world.
+    logo2: /static/img/yinminglogo.png
+    sinceDate: 2021-03-05T12:44:55.916Z
+    logo: /static/img/yinminglogo.png
+    name: 因明生物
+    nameEN: MingMed Biotech
+    type: 医疗健康
+    website: http://www.ming-med.com/
+    description: 广州因明生物医药科技有限公司是一家以First-in-Class医药创新为指引的平台型企业。因明生物拥有由多名顶级科学家、专家组成的研发团队和具有全球影响力科学家组成的科学委员会。公司在眼科药物、小分子免疫药物、新型医美药物及细胞治疗等领域均已取得具有世界水平的突破性进展。因明生物在研产品十余种，绝大部分均为具有竞争力的突破性First-in-Class创新药物，且主要产品均已完成前期研发或已经实现了产品化。为了人类更好更长的生命，因明以科学探求致病内因、创新研发医疗药物为己任，力争成为国际杰出制药企业。
+  - descriptionEN: ProfuondBio is aiming to help patients with cancer through the
+      discovery and development of novel targeted therapeutics with curative
+      potential. We are focused on discovering and advancing novel classes of
+      therapeutics that are designed to leverage the immune system to eradicate
+      cancer. For patients whose immune systems are insufficient to mount an
+      anti-cancer response, we also develop therapeutics that delivery a small
+      molecule payload specifically to tumor cells. Our team of experienced
+      scientists take a fresh look at how to best eradicate cancer by taking an
+      open, creativity approach to drug discovery and then leverage our broad
+      experience in drug development to take an efficient path to patients.
+    logo2: /static/img/pufanglogo.png
+    sinceDate: 2020-08-27T12:45:54.445Z
+    logo: /static/img/pufanglogo.png
+    name: 普方生物
+    nameEN: ProfuondBio
+    type: 医疗健康
+    website: http://www.profoundbiosz.cn/
+    description: 普方生物成立于2018年，聚焦用于实体瘤治疗的ADC药物开发领域，致力通过专有平台开发创新性靶向药物，实现对肿瘤针对性给药，达到更大治疗窗口地，从而提高和改善癌症病人的治疗效果。普方生物联合创始团队拥有多年药物研发经验，在抗体偶联药物领域积累了丰富且互补的研发经验。
+  - descriptionEN: Aldit is a biotech and biopharma startup, which is committed to
+      leverage AI technology to assist the discovery and development of novel
+      gene editing therapies. AIdit focuses on developing the cutting-edge
+      technologies based on the cooperation between the 3-high (high throughput,
+      high precision, high dimension) biotechnological data production and the
+      deep learning modeling. The AIdit team is highly multi-disciplined and has
+      gathered a group of young experts in the fields including molecular
+      biology, immunology, deep leaning and mathematics.
+    logo2: /static/img/xihuyungulogo.png
+    sinceDate: 2021-04-14T12:46:59.073Z
+    logo: /static/img/xihuyungulogo.png
+    name: 西湖云谷智药
+    nameEN: Aldit
+    type: 医疗健康
+    website: https://www.westlakegenetech.com
+    description: 西湖云谷智药致力于将人工智能技术赋能基因编辑治疗方法研发。公司开展以高通量、高精度、高维度的Biotech数据产出与深度学习模型构建相迭代的前沿技术开发，并搭建原创技术驱动的基因编辑疗法开发平台，走通人工智能技术在基因编辑治疗领域落地的全流程。公司已组建包括分子生物学、免疫学、人工智能等多学科研发团队。
+  - descriptionEN: Tomo BioSciences Ltd. (TomoBio) is a Cryo-EM and AI driven drug
+      discovery platform. Founded in 2017 at Tsinghua University with a core
+      team of outstanding life and computational scientists, AI and
+      pharmaceutical industry experts, TomoBio has successfully provided
+      structural biology and drug discovery services to more than 50 innovative
+      pharmaceutical companies and top research institutions from China, the
+      United States and Europe since its inception.
+    logo2: /static/img/shuimulogo.png
+    sinceDate: 2020-04-07T12:47:57.590Z
+    logo: /static/img/shuimulogo.png
+    name: 水木未来
+    nameEN: Tomo BioSciences
+    type: 医疗健康
+    website: https://www.shuimubio.com/
+    description: 水木未来（北京）科技有限公司是一家结构和AI计算驱动的新型药物研发平台型公司，建立了亚太第一个300kV冷冻电镜商业化服务平台，基于结构生物学、深度学习和高性能计算核心技术，在小分子、抗体药、蛋白降解、基因治疗等领域推动药物研发的数字化创新，助力全球创新药企大幅提升药物研发效率和成功率。已成功为来自中国、美国、欧洲的50余家创新药企和顶级科研机构提供了结构生物学和药物发现服务。
+  - descriptionEN: DoubleRainbow Biosciences develops transformative biotechnologies
+      to unleash the power of chemistry from the natural world to benefit
+      people’s lives. Rooted in the mechanistic understanding of specialized
+      metabolic systems in plants and other organisms, we devise novel
+      biosynthetic strategies that provide sustainable access to high-value
+      natural products of medicinal or industrial significance. Inspired by the
+      evolutionary principles underlying natural metabolic systems, we further
+      expand the chemical space beyond what nature offers. Leveraging ancient
+      wisdom distilled into the world’s traditional herbal medicines and a deep
+      knowledgebase of modern disease biology, we develop nature-inspired new
+      medicines for treating human diseases.
+    logo2: /static/img/doublerainbowlogo.png
+    sinceDate: 2020-10-20T12:48:49.491Z
+    logo: /static/img/doublerainbowlogo.png
+    name: 双虹生物科技
+    nameEN: DoubleRainbow Biosciences
+    type: 医疗健康
+    website: https://www.doublerainbowbio.com/
+    description: 双虹生物科技公司致力于开发变革性生物技术，从自然界释放化学的力量以造福人们的生活。植根于对植物和其他生物体中次生代谢系统的机理理解，我们设计了新颖的生物合成平台策略，为获得具有药用或其他工业意义的高价值天然产物提供可持续的途径。源于自然代谢系统进化原理的启发，我们进一步扩展了超出自然范围的化学空间。利用从世界传统草药中提炼出的古老智慧和现代疾病生物学的深厚知识库，我们开发以自然为灵感的新药，用于治疗人类疾病。
 ---